Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma.
Saved in:
| Title: | Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma. |
|---|---|
| Authors: | Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. agnieszka.wozniak@kuleuven.be., Boeckx B; Laboratory of Translational Genetics, KU Leuven and VIB Center for Cancer Biology, Leuven, Belgium., Modave E; Laboratory of Translational Genetics, KU Leuven and VIB Center for Cancer Biology, Leuven, Belgium., Weaver A; Global Oncology, Eisai Inc., Cambridge, Massachusetts., Lambrechts D; Laboratory of Translational Genetics, KU Leuven and VIB Center for Cancer Biology, Leuven, Belgium., Littlefield BA; Global Oncology, Eisai Inc., Cambridge, Massachusetts., Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3106-3115. Date of Electronic Publication: 2021 Apr 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-3265 |
|---|---|
| DOI: | 10.1158/1078-0432.CCR-20-4315 |
